WX-671
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for WX-671, covering 2012-03-29 to 2014-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer [Phase 2]